Search Follow us

The Biotech Growth Trust (BIOG)

Business description

The Biotech Growth Trust seeks capital appreciation through investing in the worldwide biotechnology industry, mainly in emerging biotechnology companies. Performance is measured against its benchmark index, the NASDAQ Biotechnology Index (sterling adjusted).

Stock data

Market cap.£387.7m
Last close731.00p
High / Low (52 weeks)849.0p / 600.0p
Stock market listingLN
Forecast net debt (m)N/A
Forecast gearing ratio (%)N/A
TeamInvestment Companies
SectorInvestment trusts

Other companies in sector Show

Aberdeen Asian Income Fund Aberdeen Latin American Income Fund
Aberdeen New Dawn Investment Trust Aberdeen New Thai Investment Trust
Aberdeen Private Equity Fund Aberdeen Standard Equity Income Trust
Aberdeen UK Tracker Trust AcenciA Debt Strategies
Acorn Income Fund Adamas Finance Asia
Alliance Trust Altamir SCA
Amphion Innovations Atlantis Japan Growth Fund
Aurelius Bailador Tech Investments
Baker Steel Resources Trust Bankers Investment Trust (The)
BB Biotech BioPharma Credit
BlackRock Emerging Europe BlackRock Greater Europe Investment Trust
BlackRock Hedge Selector BlackRock Latin American Inv. Trust
BMO Managed Portfolio Trust Growth Portfolio BMO Managed Portfolio Trust Income Portfolio
British Portfolio Trust Brunner Investment Trust (The)
Canadian General Investments Carador Income Fund
CFP Sanford DeLand Free Spirit Fund. Charles Stanley
City Natural Resources Conversus Capital
CQS Rig Finance Fund CVC Credit Partners European Opps
Detour Gold Deutsche Beteiligungs
Dexion Commodities Diverse Income Trust (The)
DouglasBay Capital Dunedin Enterprise Investment Trust
DW Catalyst Fund Edinburgh Worldwide Investment Trust (The)
EJF Investments European Assets Trust
F&C Investment Trust Fidelity Asian Values
Fidelity China Special Situations Fidelity European Values
Fidelity Japan Trust Fidelity Special Values
Finsbury Growth & Income Trust Gartmore Growth Opportunities
Gartmore Irish Growth Fund Geiger Counter Limited
Genesis Emerging Markets Fund GLI Alternative Finance
Global Resources Investment Trust Golden Prospect Precious Metals
Gulf Investment Fund Hansa Trust
HarbourVest Global Private Equity HarbourVest Senior Loans Europe
HBM Healthcare Investments Heliad Equity Partners
Henderson Alternative Strategies Trust Henderson Far East Income
Henderson Global Trust Henderson Global Trust
Henderson International Income Trust Heptagon
HSBC Infrastructure Company Infrastructure India
International Biotechnology Trust Invesco Asia Trust
Invesco Income Growth Trust Is Private Equity
JP Morgan Private Equity Limited JPMorgan Brazil Investment Trust
JPMorgan European Smaller Companies Trust JPMorgan Global Convertibles Income Fund
JPMorgan Global Growth & Income JPMorgan Indian Investment Trust
Jupiter Green Investment Trust Jupiter UK Growth Investment Trust
Jupiter US Smaller Companies JZ Capital Partners Limited
Lazard World Trust Fund Leaf Clean Energy Company
LMS Capital Lowland Investment Company
LPeC Marble Point Loan Financing
Martin Currie Asia Unconstrained Trust Martin Currie Global Portfolio Trust
Middlefield Canadian Income Miton Global Opportunities
Miton Income Opportunities Trust Murray Income Trust
Murray International Trust New City Energy
Ocean Wilsons Holdings Odyssean Investment Trust
Pacific Assets Trust Phaunos Timber Fund
Polar Capital Global Financials Trust Polar Capital Global Healthcare Trust
Princess Private Equity Holding PXP Vietnam Fund
Rathbone Brothers RENN Universal Growth Investment Trust
Schroder AsiaPacific Fund Schroder Global Real Estate Securities
ScotGems Scottish Oriental Smaller Companies
Sealand Capital Galaxy Securities Trust of Scotland
Seneca Global Income & Growth Trust Sigma Capital Group
Standard Life Investments Property Income Trust Standard Life Private Equity Trust
Standard Life UK Smaller Companies Strategic Equity Capital
Taiwan Fund (The) Templeton Emerging Markets Investment Trust
Tetragon Financial Group The European Investment Trust
The Global Sustainability Trust The Law Debenture Corporation
The Merchants Trust The North American Income Trust
The Scottish Investment Trust Tiso Blackstar Group
Toscafund Asset Management TR European Growth Trust
UK Commercial Property REIT Utilico Emerging Markets Trust
Vietnam Enterprise Investments Vietnam Holding Asset Management
Vietnam Infrastructure Fund VinaCapital Vietnam Opportunity Fund
VinaLand Vision Opportunity China Fund
Volta Finance WAM Active
WAM Capital WAM Research
Witan Investment Trust Witan Pacific Investment Trust
Worldwide Healthcare Trust YFM Equity Partners

Company news

The Biotech Growth Trust Appoints Hsu To Board As Borho Retires

Wed, 16 May 2018 16:45:49 GMT

£10000 into £31000 in three years: can this fund keep rising?

Wed, 24 Sep 2014 10:43:47 GMT

Biotech sell-off hurts Woodford trust and specialist funds

Thu, 15 Oct 2015 11:15:33 GMT

The sector housing the best trusts for NAV returns over the last decade

Fri, 22 Sep 2017 09:10:05 GMT

Investment Trust Watch: biotech boom throws up 'bargains'

Thu, 22 Jun 2017 13:13:17 GMT

Investment summary

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu and Richard Klemm at OrbiMed Capital, one of the leading global healthcare asset managers. The year 2018 proved to be tough for the trust’s performance as biotech companies delivering negative news were heavily penalised, while those delivering good news went unrewarded. However, the managers are optimistic about BIOG’s prospects. They cite a rich industry innovation pipeline that includes a series of technologies with multi-billion-dollar revenue potential; a favourable regulatory environment; and a higher level of deal activity, including major pharma company Bristol-Myers Squibb’s recent bid for Celgene (one of BIOG’s largest holdings) at a significant premium to its pre-bid share price.

Last updated on 15/02/2019

Key management

Andrew Joy, Chairman
Richard Klemm, Fund manager
Geoffrey Hsu, Fund manager

Company address

One Wood Street
London
EC2V 7WS
United Kingdom
View website